Assistant Professor, Medicine, Johns Hopkins University School of Medicine

Pulmonology

Zaiman practices Pulmonology. He went to medical school at Albert Einstein College of Medicine of Yeshiva University. Zaiman is also published. He has 35 publications published. The lastest publication: "CBF, Myb, and Ets binding sites are important for activity of the core I element of the murine retrovirus SL3-3 in T lymphocytes.' Zaiman is registered with Medicare.

Publications

---

• Pulmonary arterial hypertension: MR imaging-derived first-pass bolus kinetic parameters are biomarkers for Pulmonary hemodynamics, cardiac function, and ventricular re...
• The gain-of-function Chinese hamster ovary mutant LEC11B expresses one of two Chinese hamster FUT6 genes due to the loss of a negative regulatory factor.
• Addition of sildenafil to bosentan monotherapy in Pulmonary arterial hypertension.
• One hundred years of research in the pathogenesis of Pulmonary hypertension.
• Intracellular interaction of myosin light chain kinase with macrophage migration inhibition factor (MIF) in endothelium.
• Endothelial cell myosin light chain kinase (MLCK) regulates TNFalpha-induced NFkappaB activity.
• Impaired transforming growth factor-beta signaling in idiopathic Pulmonary arterial hypertension.
• Caspase-dependent cleavage of myosin light chain kinase (MLCK) is involved in TNF-alpha-mediated bovine Pulmonary endothelial cell apoptosis.
• Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products.
• Mutation analysis of the non-muscle myosin light chain kinase (MLCK) deletion constructs on CV1 fibroblast contractile activity and proliferation.
• Phospholipase D activation by sphingosine 1-phosphate regulates interleukin-8 secretion in human bronchial epithelial cells.
• Prostacyclin analogs as the brakes for Pulmonary artery smooth muscle cell proliferation: is it sufficient to treat severe Pulmonary hypertension?
• Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models.
• Survival in Pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
• Treatment of sarcoidosis-associated Pulmonary hypertension. A two-center experience.
• Identification of candidate genes in scleroderma-related Pulmonary arterial hypertension.
• Role of the TGF-beta/Alk5 signaling pathway in monocrotaline-induced Pulmonary hypertension.
• PDE5A inhibition attenuates bleomycin-induced Pulmonary fibrosis and Pulmonary hypertension through inhibition of ROS generation and RhoA/Rho kinase activation.
• Digoxin inhibits development of hypoxic Pulmonary hypertension in mice.
• A critical role for the protein apoptosis repressor with caspase recruitment domain in hypoxia-induced Pulmonary hypertension.
• MicroRNA profiling of diverse endothelial cell types.
• Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated Pulmonary arterial hypertension.
• Systemic sclerosis-related Pulmonary hypertension associated with interstitial lung disease: impact of Pulmonary arterial hypertension therapies.
• Pivotal role of cardiomyocyte TGF-? signaling in the murine pathological response to sustained pressure overload.
• Phosphodiesterase-5A (PDE5A) is localized to the endothelial caveolae and modulates NOS3 activity.
• Schistosomiasis-induced experimental Pulmonary hypertension: role of interleukin-13 signaling.
• Hemodynamic predictors of survival in scleroderma-related Pulmonary arterial hypertension.
• PDE5A inhibitor treatment of persistent Pulmonary hypertension after mechanical circulatory support.
• Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related Pulmonary hypertension.
• Outcomes of hospitalisation for right heart failure in Pulmonary arterial hypertension.
• CBF, Myb, and Ets binding sites are important for activity of the core I element of the murine retrovirus SL3-3 in T lymphocytes.
• Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb.
• Transcriptional activity of core binding factor-alpha (AML1) and beta subunits on murine leukemia virus enhancer cores.
• Identification and association of polymorphisms in the interleukin-13 gene with Asthma and atopy in a Dutch population.

Schools

---

• Albert Einstein College of Medicine of Yeshiva University

Procedures Preformed

---

• Bronchoscopy
• Thoracentesis
• Ventilation Management

Conditions Treated

---

• Acidosis
• Asthma
• Atelectasis
• Bronchiectasis
• View All

Doctors Specialties

---

• Critical Care Medicine
• Pulmonology

Accepted Insurances

---

Education

---

• Johns Hopkins University
• University of Maryland
• Albert Einstein College of Medicine of Yeshiva University

Drug Facts

---

NPI NUMBER		1104862572
NPPES Provider LastName		ZAIMAN
NPPES Provider FirstName		ARI
NPPES Provider ZIPCode		214013280
NPPES Provider State		MD
Specialty Description		Pulmonary Disease
Total Claim Count		209.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1104862572
Last Name Of The Provider	ZAIMAN
First Name Of The Provider	ARI
View All

Similar Doctors

---

	Dr. Stanley D. Krimins, MD This Doctor is OpenDoctor Recommended.
	Dr. Richard A. Bernstein, MD This Doctor is OpenDoctor Recommended.
	Dr. Sjoerd Beck, MD This Doctor is OpenDoctor Recommended.
	Dr. Dennis F. Frank, MD
	Dr. Adil T. Degani, MD This Doctor is OpenDoctor Recommended.
	Dr. Wayne S. Andersen, DO
	Dr. Keith E. Goulet, DO This Doctor is OpenDoctor Recommended.
	Dr. A T. Walman, MD This Doctor is OpenDoctor Recommended.
	Dr. Stephen M. Olexo, MD This Doctor is OpenDoctor Recommended.
	Dr. Howard S. Young, MD This Doctor is OpenDoctor Recommended.
	Dr. Kanak R. Patel, MD This Doctor is OpenDoctor Recommended.
	Mark P. Hamill, MB BCH This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog